Alnylam Pharmaceuticals Inc. (ALNY) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Alnylam Pharmaceuticals I...

    NASDAQ: ALNY · Real-Time Price · USD
    446.40
    -3.18 (-0.71%)
    At close: Sep 26, 2025, 3:59 PM
    452.00
    1.25%
    After-hours: Sep 26, 2025, 07:50 PM EDT

    Alnylam Pharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 966.43M 812.69M 866.39M 819.98M
    Short-Term Investments
    		 1.73B 1.63B 1.33B 1.62B
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 133.9M 111.29M 115.48M 101.09M
    Receivables
    		 405.31M 327.79M 237.96M 198.57M
    Inventory
    		 78.51M 89.15M 128.96M 86.36M
    Other Current Assets
    		 116.96M 126.38M 132.92M n/a
    Total Current Assets
    		 3.3B 2.98B 2.69B 2.81B
    Property-Plant & Equipment
    		 693.93M 725.79M 738.63M 733.63M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 944.7M 847.18M 854.11M 834.73M
    Total Assets
    		 4.24B 3.83B 3.55B 3.64B
    Account Payables
    		 88.42M 55.52M 98.09M 73.43M
    Deferred Revenue
    		 55.48M 102.75M 42.1M 149.48M
    Short-Term Debt
    		 n/a n/a n/a n/a
    Other Current Liabilities
    		 327.42M 177.16M 170.98M 130.66M
    Total Current Liabilities
    		 1.19B 967.79M 767.91M 695.71M
    Long-Term Debt
    		 1.02B 1.02B 1.02B 675.7M
    Other Long-Term Liabilities
    		 1.73B 1.63B 1.46B 1.25B
    Total Long-Term Liabilities
    		 2.99B 3.08B 2.94B 2.36B
    Total Liabilities
    		 4.17B 4.05B 3.7B 3.06B
    Total Debt
    		 1.3B 1.31B 1.32B 997.59M
    Book Value
    		 67.09M -220.64M -158.22M 588.2M
    Book Value Per Share
    		 0.53 -1.77 -1.3 4.97
    Common Stock
    		 1.29M 1.26M 1.24M 1.2M
    Retained Earnings
    		 -7.29B -7.01B -6.57B -5.44B
    Comprehensive Income
    		 -34.52M -23.38M -44.65M -33.26M
    Shareholders Equity
    		 67.09M -220.64M -158.22M 588.2M
    Total Investments
    		 1.73B 1.63B 1.33B 1.62B

    Add to Watchlist